81 related articles for article (PubMed ID: 34588605)
1. Antibodies targeting human endothelin-1 receptors reveal different conformational states in cancer cells.
Herbet A; Costa N; Leventoux N; Mabondzo A; Couraud JY; Borrull A; Hugnot JP; Boquet D
Physiol Res; 2018 Jun; 67(Suppl 1):S257-S264. PubMed ID: 29947545
[TBL] [Abstract][Full Text] [Related]
2. Unraveling the physiological roles of retinoic acid receptor-related orphan receptor α.
Lee JM; Kim H; Baek SH
Exp Mol Med; 2021 Sep; 53(9):1278-1286. PubMed ID: 34588606
[TBL] [Abstract][Full Text] [Related]
3. Oncoinformatic screening of the gene clusters involved in the HER2-positive breast cancer formation along with the in silico pharmacodynamic profiling of selective long-chain omega-3 fatty acids as the metastatic antagonists.
Morshed AKMH; Al Azad S; Mia MAR; Uddin MF; Ema TI; Yeasin RB; Srishti SA; Sarker P; Aurthi RY; Jamil F; Samia NSN; Biswas P; Sharmeen IA; Ahmed R; Siddiquy M; Nurunnahar
Mol Divers; 2023 Dec; 27(6):2651-2672. PubMed ID: 36445532
[TBL] [Abstract][Full Text] [Related]
4. A robust antibody discovery platform for difficult-to-express G protein-coupled receptors.
Kim NH; Kang S; Park GH; Shim G; Kang TH; Yu YG
Protein Sci; 2023 Jan; 32(1):e4520. PubMed ID: 36419382
[TBL] [Abstract][Full Text] [Related]
5. Application of extracellular vesicles from mesenchymal stem cells promotes hair growth by regulating human dermal cells and follicles.
Rajendran RL; Gangadaran P; Kwack MH; Oh JM; Hong CM; Sung YK; Lee J; Ahn BC
World J Stem Cells; 2022 Jul; 14(7):527-538. PubMed ID: 36157528
[TBL] [Abstract][Full Text] [Related]
6. Development of a human antibody that exhibits antagonistic activity toward CC chemokine receptor 7.
Jang MS; Ismail NSB; Yu YG
Antib Ther; 2022 Jul; 5(3):192-201. PubMed ID: 35967907
[TBL] [Abstract][Full Text] [Related]
7. Radiation-induced cardiac side-effects: The lung as target for interacting damage and intervention.
Wiedemann J; Coppes RP; van Luijk P
Front Oncol; 2022; 12():931023. PubMed ID: 35936724
[TBL] [Abstract][Full Text] [Related]
8. Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines.
Khetan R; Dharmayanti C; Gillam TA; Kübler E; Klingler-Hoffmann M; Ricciardelli C; Oehler MK; Blencowe A; Garg S; Albrecht H
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35625966
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin and Endothelin Receptor Structures With Implications for Signaling Regulation and Pharmacological Targeting.
Speck D; Kleinau G; Szczepek M; Kwiatkowski D; Catar R; Philippe A; Scheerer P
Front Endocrinol (Lausanne); 2022; 13():880002. PubMed ID: 35518926
[TBL] [Abstract][Full Text] [Related]
10. Methods for assessing endothelin ETA-receptor antagonists in preclinical studies.
Okada M; Siegl PK; Nishikibe M
Methods Find Exp Clin Pharmacol; 2002; 24(6):361-70. PubMed ID: 12224443
[TBL] [Abstract][Full Text] [Related]
11. β-arrestin1 at the cross-road of endothelin-1 signaling in cancer.
Rosanò L; Bagnato A
J Exp Clin Cancer Res; 2016 Jul; 35(1):121. PubMed ID: 27473335
[TBL] [Abstract][Full Text] [Related]
12. A human antibody against human endothelin receptor type A that exhibits antitumor potency.
Ju MS; Ahn HM; Han SG; Ko S; Na JH; Jo M; Lim CS; Ko BJ; Yu YG; Lee WK; Kim YJ; Jung ST
Exp Mol Med; 2021 Sep; 53(9):1437-1448. PubMed ID: 34588605
[TBL] [Abstract][Full Text] [Related]
13. Engineered Human Antibody with Improved Endothelin Receptor Type A Binding Affinity, Developability, and Serum Persistence Exhibits Excellent Antitumor Potency.
Ko S; Ju MS; Ahn HM; Na JH; Ko WH; Jo M; Kyung M; Lim CS; Ko BJ; Lee WK; Kim YJ; Jung ST
Mol Pharm; 2023 Feb; 20(2):1247-1255. PubMed ID: 36563318
[TBL] [Abstract][Full Text] [Related]
14. Comparison of human ETA and ETB receptor signalling via G-protein and β-arrestin pathways.
Maguire JJ; Kuc RE; Pell VR; Green A; Brown M; Kumar S; Wehrman T; Quinn E; Davenport AP
Life Sci; 2012 Oct; 91(13-14):544-9. PubMed ID: 22480514
[TBL] [Abstract][Full Text] [Related]
15. Generation and characterization of a target-selectively activated antibody against epidermal growth factor receptor with enhanced anti-tumor potency.
Yang Y; Guo Q; Xia M; Li Y; Peng X; Liu T; Tong X; Xu J; Guo H; Qian W; Hou S; Dai J; Wang H; Liu R; Guo Y
MAbs; 2015; 7(2):440-50. PubMed ID: 25679409
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
